Apellis Pharmaceuticals
APLS
#3545
Rank
S$3.76 B
Marketcap
$30.01
Share price
-2.09%
Change (1 day)
-60.90%
Change (1 year)

Apellis Pharmaceuticals (APLS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$0.87 Billion

According to Apellis Pharmaceuticals's latest financial reports the company's total liabilities are S$0.87 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Apellis Pharmaceuticals - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.89 B13.71%
2023-12-31S$0.78 B-0.84%
2022-12-31S$0.79 B-14.3%
2021-12-31S$0.92 B-7.67%
2020-12-31S$1.00 B108.96%
2019-12-31S$0.47 B723.16%
2018-12-31S$58.14 M30.99%
2017-12-31S$44.38 M742.85%
2016-12-31S$5.26 M16.35%
2015-12-31S$4.52 M216.76%
2014-12-31S$1.42 M66.62%
2013-12-31S$0.85 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$41.34 M-95.28%๐Ÿ‡บ๐Ÿ‡ธ USA